Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.360
+0.140 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
4.415
+0.055 (1.26%)
After-hours: Mar 9, 2026, 5:24 PM EDT

Company Description

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications.

The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.

It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments.

In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools.

Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names.

The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations.

It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries.

The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015.

Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Cytek Biosciences, Inc.
Cytek Biosciences logo
Country United States
Founded 1990
IPO Date Jul 23, 2021
Industry Medical Devices
Sector Healthcare
Employees 702
CEO Wenbin Jiang

Contact Details

Address:
47215 Lakeview Blvd
Fremont, California 94538-6407
United States
Phone 877 922 9835
Website cytekbio.com

Stock Details

Ticker Symbol CTKB
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001831915
CUSIP Number 23285D109
ISIN Number US23285D1090
Employer ID 47-2547526
SIC Code 3826

Key Executives

Name Position
Dr. Wenbin Jiang Ph.D. President, Chief Executive Officer and Chairman of the Board
William D. McCombe Chief Financial Officer
Dr. Ming Yan Ph.D. Chief Technology Officer and Director
Valerie T. Barnett J.D. Chief Legal Officer and Corporate Secretary
Dr. Philippe Busque Ph.D. Senior Vice President of Global Sales and Services
Patrik Sebastian Jeanmonod Head of Corporate Development Analytics

Latest SEC Filings

Date Type Title
Feb 27, 2026 S-8 Securities to be offered to employees in employee benefit plans
Feb 26, 2026 10-K Annual Report
Feb 26, 2026 8-K Current Report
Jan 13, 2026 8-K Current Report
Nov 17, 2025 SCHEDULE 13G Filing
Nov 12, 2025 SCHEDULE 13G/A Filing
Nov 5, 2025 10-Q Quarterly Report
Nov 5, 2025 8-K Current Report
Aug 6, 2025 10-Q Quarterly Report
Aug 6, 2025 8-K Current Report